Please Wait
Applying Filters...
menu
    • menu
    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-23

    Virtual Booth

    An Enquiry

    Menu

    Soquelitinib

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Corvus Pharmaceuticals Presents Soquelitinib Preclinical Data at
    Corvus Pharmaceuticals Presents Soquelitinib Preclinical Data at

    11 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/11/3097429/0/en/Corvus-Pharmaceuticals-Presents-Soquelitinib-Preclinical-Data-Highlighting-Potential-of-ITK-inhibition-to-Treat-Systemic-Sclerosis-at-EULAR-2025-Congress.html

    GLOBENEWSWIRE
    11 Jun 2025
    Share Share
    Corvus Shares Full Ph1 Data for Soquelitinib in Atopic Dermatitis
    Corvus Shares Full Ph1 Data for Soquelitinib in Atopic Dermatitis

    04 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/04/3093421/0/en/Corvus-Pharmaceuticals-Announces-Full-Data-from-Cohort-3-of-Placebo-Controlled-Phase-1-Clinical-Trial-of-Soquelitinib-for-Atopic-Dermatitis.html

    GLOBENEWSWIRE
    04 Jun 2025
    Share Share
    Corvus Pharmaceuticals Releases Data from Soquelitinib Trial
    Corvus Pharmaceuticals Releases Data from Soquelitinib Trial

    08 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/08/3077670/0/en/Corvus-Pharmaceuticals-Announces-Data-from-Cohorts-1-3-of-Placebo-Controlled-Phase-1-Clinical-Trial-of-Soquelitinib-for-Atopic-Dermatitis.html

    GLOBENEWSWIRE
    08 May 2025
    Share Share
    Corvus Pharmaceuticals to Present New Data on Soquelitinib Trial
    Corvus Pharmaceuticals to Present New Data on Soquelitinib Trial

    23 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/23/3066897/0/en/Corvus-Pharmaceuticals-to-Present-New-Interim-Data-from-Placebo-Controlled-Phase-1-Clinical-Trial-of-Soquelitinib-for-Atopic-Dermatitis-on-May-8-2025.html

    GLOBENEWSWIRE
    23 Apr 2025
    Share Share
    Corvus Presents Additional Data on Soquelitinib for T Cell Lymphoma
    Corvus Presents Additional Data on Soquelitinib for T Cell Lymphoma

    20 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/20/3046156/0/en/Corvus-Pharmaceuticals-Announces-Presentation-of-Additional-Data-from-the-Phase-1-1b-Clinical-Trial-of-Soquelitinib-for-Patients-with-T-Cell-Lymphoma.html

    GLOBENEWSWIRE
    20 Mar 2025
    Share Share
    Corvus Starts Ph2 Trial Of Soquelitinib For ALPS Patients
    Corvus Starts Ph2 Trial Of Soquelitinib For ALPS Patients

    12 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2025/03/12/3041299/0/en/Corvus-Pharmaceuticals-Announces-Initiation-of-Phase-2-Clinical-Trial-of-Soquelitinib-for-Patients-with-Autoimmune-Lymphoproliferative-Syndrome-ALPS.html

    GLOBENEWSWIRE
    12 Mar 2025
    Share Share